Pfizer/BioNTech seek first vaccine approval in US


WASHINGTON (AFP) – United States (US) biotech giant Pfizer and German partner BioNTech sought approval on Friday to roll out their coronavirus vaccine early, a first step towards relief as surging infections prompt a return to shutdowns that traumatised nations and the global economy earlier this year. More details in Sunday’s Borneo Bulletin.